Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003)
~48 mi.
(Morelia,
Mexico,
+93 more cities)
Centro de Investigacion Clinica Chapultepec ( Site 0400)